Publication | Closed Access

Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure

Heart FailureCardiovascular DiseaseCardiovascular PharmacologyCardiac CareCongestive Heart FailureAtrial FibrillationIntravenous DiltiazemPublic HealthMedicineCardiologyDiastolic FunctionAnesthesiology